Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress
04-Feb-2016 - Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.
News in brief
03-Feb-2016 - Up to 80 UK sterile manufacturing jobs could be lost as part of a technical overhaul at a Teva site near Liverpool.
02-Feb-2016 - Reneuron has been granted a US patent for a cryopreservation technology that does not rely on toxic reagents and says it would consider licensing it to other stem cell therapy developers on a case-by-case basis.
29-Jan-2016 - Biocision has revamped its cell thawing platform to accommodate larger vial sizes and started developing an automated system for cell therapies in cryopreservation bags.
28-Jan-2016 - More plants in China will close says a US-based analyst who predicts that some drugmakers' inability to comply with stricter quality rules will create an opportunity for those that can.
28-Jan-2016 - Plans to centralise its manufacturing operations will optimise use of new technologies across Novartis’s divisions without resulting in any additional facility closures, the firm says.
26-Jan-2016 - Hermes Pharma has added hot melt coating capabilities to its offering and hopes the food industry technique will win it pharma customers with unpleasant tasting APIs.
26-Jan-2016 - Yan Mei, a defendant charged with stealing GlaxoSmithKline (GSK) trade secrets including biopharmaceutical manufacturing processes, remains at large, a spokesperson for the US Attourney's office told us yesterday.